Bio-Gene Technology Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 0.149232 million compared to AUD 0.445726 million a year ago. Revenue was AUD 0.68129 million compared to AUD 0.939118 million a year ago.

Net loss was AUD 3.1 million compared to AUD 2.91 million a year ago. Basic loss per share from continuing operations was AUD 0.0185 compared to AUD 0.019 a year ago. Diluted loss per share from continuing operations was AUD 0.0185 compared to AUD 0.019 a year ago.